Novavax (NVAX) Amortization of Deferred Charges (2016 - 2020)

Novavax's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $356000.0 for Q4 2020.

• In Q4 2020, Amortization of Deferred Charges changed 0.0% year-over-year to $356000.0; the TTM figure through Dec 2020 stood at $1.4 million (changed 0.0% YoY), while the FY2020 annual figure was $1.4 million, changed 0.0% from the prior year.
• Amortization of Deferred Charges was $356000.0 for Q4 2020 at Novavax, roughly flat from $356000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $357000.0 in Q4 2017 to a low of $237000.0 in Q1 2016.
• Historically, Amortization of Deferred Charges has averaged $349789.5 across 5 years, with a median of $356000.0 in 2016.
• The sharpest annual moves came in 2017 and 2018: Amortization of Deferred Charges jumped 50.21% in 2017, then declined 0.28% in 2018.
• A 5-year view of Amortization of Deferred Charges shows it stood at $356000.0 in 2016, then grew by 0.28% to $357000.0 in 2017, then fell by 0.28% to $356000.0 in 2018, then changed by 0.0% to $356000.0 in 2019, then changed by 0.0% to $356000.0 in 2020.
• The last three Amortization of Deferred Charges figures came in at $356000.0 (Q4 2020), $356000.0 (Q3 2020), and $356000.0 (Q2 2020), per Business Quant data.